|
 Regeneron antibodies in demand
Patients are asking to join clinical trials of antibody-based
COVID-19 drugs after U.S. President Donald Trump was treated with an
experimental therapy from Regeneron Pharmaceuticals Inc. On
Wednesday he touted its benefits while promising to make it free to
Americans.
Medical experts said more data is needed to assess the treatment's
efficacy before wider use should be allowed.
Regeneron's drug is a cocktail of two monoclonal antibodies -
manufactured copies of antibodies that are one of the main weapons
the immune system generates to fight infections.
Pentagon risk grows
The U.S. Marine Corps said its No. 2 officer, General Gary Thomas,
had tested positive for COVID-19, becoming the second senior
military official to do so this week. Thomas, the Marine Corps'
assistant commandant, is suffering mild symptoms and is
self-quarantining at home, it said.
Nearly all the Joint Chiefs of Staff, including its chairman, Army
General Mark Milley, are in quarantine after attending top-level
meetings last week with Thomas and the Coast Guard's No. 2 official,
Admiral Charles Ray, who tested positive on Monday.
Europe stocks up on remdesivir
Gilead Sciences said it had agreed to sell Europe up to 500,0000
courses of its antiviral drug remdesivir, as the continent shores up
supplies of one of only two drugs approved to treat COVID-19
patients.
The deal will cover purchases of the drug for the next six months
for 37 countries: the 27-nation European Union, Britain, six Balkan
countries and the other European Economic Area countries - Iceland,
Liechtenstein and Norway.
[to top of second column] |
Several European countries have said they are experiencing shortages
of the drug, whose global stock has been secured almost entirely by
the United States.
Germany's cases start to spiral
The daily tally of new coronavirus cases in Germany leapt by almost
half, official data showed on Thursday, a day after ministers agreed
emergency measures to tamp down on domestic tourism.
The number of confirmed coronavirus cases increased by 4,058 to
310,144, a rate not seen since April, lending weight to officials'
warnings that Germany is headed down the path of its neighbours if
citizens don't adhere to rigid social distancing.
Berlin and Frankfurt have already imposed a curfew on evening
entertainment.
Warsaw to face new curbs
Poland's daily coronavirus cases surged over 40% on Thursday
compared to the previous day, just as the capital Warsaw was set to
be added to a list of areas with additional restrictions.
Poland faces spiralling infection rates, and while authorities have
sought to reassure the public that hospitals can cope, doctors have
warned that the system could soon face serious difficulties.
Other central and eastern European countries are also facing sharp
increases, with the Czech Republic and Slovakia both reporting
record numbers of cases on Thursday.
(Compiled by Linda Noakes; Editing by Frances Kerry)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
